MedicarePartD.guide

A non-government resource built from CMS public data

Fetzima on Blue Cross MedicareRx Basic (S5715-013)

levomilnacipran hydrochloride

Covered.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$220.07
Patient pays / month, after deductible
$550.18
Patient pays / month, before the $615.00 deductible
$660.22
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FETZIMA 20 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $550.18 for a month. Other covered strengths are listed below.

All 5 covered strengths and forms
FormTierPatient pays / monthLimits
FETZIMA 120 mg Capsule, Extended Release4$228.9630 per 30 days
FETZIMA 20 mg Capsule, Extended Release4$220.0730 per 30 days
FETZIMA 40 mg Capsule, Extended Release4$230.3330 per 30 days
FETZIMA 80 mg Capsule, Extended Release4$225.1430 per 30 days
FETZIMA Kit4$230.2328 per 28 days

Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5715-013